Appendix
Rational Use of FIGO Guidelines in Clinical
Practice
The International Federation of Gynecology and Obstetrics (FIGO) released its revised
guidelines on CTG in October 2015 in collaboration with 37 member societies and with
a consensus panel comprising of 50 CTG experts around the world.
Table A1 CTG Classification Criteria, Interpretation and Recommended Management
Normal Suspicious Pathological
Baseline 110–160 Lacking at
le
astonecharacteristic
ofnormality, but with
nopathological
features
<100 bpm
Variability 5–25 Reduced variability for > 50
min, increased variability for
>30 min, or sinusoidal pattern
for > 30 min
Decelerations No repetitive*
decelerations
Repetitive* late or prolonged
decelerations during >30 min
or 20 min if reduced
variability, or one prolonged
deceleration >5 min
Interpretation Fetus with no
hypoxia/acidosis
Fetus with a low
probability of having
hypoxia/acidosis
Fetus with a high probability
of having hypoxia/acidosis
Clinical
management
No intervention
necessary to
imp
rove fetal
oxygenation
state
Action to correct
reversible causes if
identified, close
monitoring or
additional methods
to evaluate fetal
Immediate action to correct
reversible causes, additional
methods to evaluate fetal
oxygenation (Chapter 4), or if
this is not posible, expedite
delivery; in acute situationsoxygenation (cord prolapse, uterine rupture
or placental abruption),
imm
ediate delivery should be
accomplished
The presence of accelerations denotes a fetus that does not have hypoxia/acidosis, but their
absence during labour is of uncertain significance.
* Decelerations are repetitive in nature when they are associated with >50 percent of
uterine contractions.
Clinical Decision
Several factors, including gestational age and medication administered to the mother,
can affect FHR features, so CTG analysis needs to be integrated with other clinical
information for a comprehensive interpretation and adequate management. As a general
rule, if the fetus continues to maintain a stable baseline and a reassuring variability, the
risk of hypoxia to the central organs is very unlikely. However, the general principles
that should guide clinical management are outlined in the table.
FIGO guidelines clearly state that when fetal hypoxia/acidosis is anticipated or
suspected (suspicious and pathological tracings) and action is required to avoid adverse
neonatal outcome, this does not necessarily mean an immediate caesarean section or
instrumental vaginal delivery. The underlying cause for the appearance of the pattern can
frequently be identified and the situation reversed with subsequent recovery of adequate
fetal oxygenation and return to a normal tracing.
Good clinical judgement is required to diagnose the underlying cause for a
suspicious or pathological CTG to judge the reversibility of the conditions with which it
is associated and to determine the timing of delivery with the objective of avoiding
prolonged fetal hypoxia/acidosis as well as unnecessary obstetric intervention.
Additional methods may be used to evaluate fetal oxygenation. When a suspicious or
worsening CTG pattern is identified, the underlying cause should be addressed before a
pathological tracing develops. If the situation does not revert and the pattern continues to
deteriorate, consideration needs to be given for further evaluation or rapid delivery if a
pathological pattern ensues.During the second stage of labour, due to the additional effect of maternal pushing,
hypoxia/acidosis may develop more rapidly. Therefore, urgent action should be
undertaken to relieve the situation, including discontinuation of maternal pushing, and if
there is no improvement, delivery should be expedited
Implementation of FIGO Guidelines in Clinical
Practice
It is important that midwives and obstetricians employ the principles of fetal physiology
and physiological response to intrapartum hypoxic stress prior to taking action after
classifying the CTG trace as normal, suspicious or pathological. Baseline FHR should
be considered in accordance with the gestational age of the fetus (i.e. a postterm fetus
would be expected to have a lower baseline heart rate), as well as a rise in baseline
heart rate due to catecholamine surge may need action, even though the upper limit of the
threshold (i.e. 160 bpm) is not breached. It is important to determine the presence of
cycling and types of hypoxia while interpreting CTG traces.
Even if the CTG is classified as pathological, in the presence of a stable baseline
FHR and reassuring variability, usually no operative intervention is required other than
careful observation and/or alleviation of the cause of hypoxic or mechanical stress.
Conversely, a fetus with a ‘normal CTG’ may require an operative intervention (e.g.
clinical chorioamnionitis with failure to progress in labour). The presence of meconium
staining of amniotic fluid and ongoing clinical chorioamnionitis may result in
neurological injury secondary to meconium aspiration syndrome and inflammatory brain
damage, even if the CTG trace is not ‘pathological’. The use of tocolytics may help
improve utero-placental circulation if acute accidents such as placental abruption or
uterine rupture are excluded.
Further Reading
1. Ayres-de-Campos D, Spong CY, Chandraharan E; FIGO Intrapartum Fetal Monitoring
Expert Consensus Panel. FIGO consensus guidelines on intrapartum fetal monitoring:Cardiotocography. Int J Gynaecol Obstet. 2015;131(1):13–24. www.ijgo.org/article/S0020-
7292%2815%2900395-1/fulltext
Nhận xét
Đăng nhận xét